Author: Cargill, Tamsin; Barnes, Eleanor
Title: Therapeutic vaccination for treatment of chronic hepatitis B Cord-id: mlfk3bk6 Document date: 2021_6_8
ID: mlfk3bk6
Snippet: Chronic hepatitis B infection remains a serious global health threat, contributing to a large number of deaths through liver cirrhosis and hepatocellular carcinoma. Current treatment does not eradicate disease, and therefore new treatments are urgently needed. In acute hepatitis B virus (HBV) a strong immune response is necessary to clear the virus, but in chronic infection the immune response is weakened and dysfunctional. Therapeutic vaccination describes the process of inoculating individuals
Document: Chronic hepatitis B infection remains a serious global health threat, contributing to a large number of deaths through liver cirrhosis and hepatocellular carcinoma. Current treatment does not eradicate disease, and therefore new treatments are urgently needed. In acute hepatitis B virus (HBV) a strong immune response is necessary to clear the virus, but in chronic infection the immune response is weakened and dysfunctional. Therapeutic vaccination describes the process of inoculating individuals with a nonâ€infective form of viral antigen with the aim of inducing or boosting existing HBVâ€specific immune responses, resulting in sustained control of HBV infection. In this review we outline the rationale for therapeutic vaccination in chronic HBV infection, discuss previous and ongoing trials of novel HBV therapeutic vaccine candidates and outline strategies to improve vaccine efficacy going forward.
Search related documents:
Co phrase search for related documents- absence presence and action mechanism: 1, 2, 3, 4, 5, 6
- absence presence and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- absence presence and adaptive immune response: 1, 2
- absence presence and additional benefit: 1, 2
- absence presence and adenoviral vector: 1
- absence presence and adenovirus antibody: 1
- absence presence and liver biopsy: 1
- absence presence and liver cirrhosis: 1, 2, 3, 4, 5
- action mechanism and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- action mechanism and adaptive immune response: 1, 2, 3
- action mechanism and liver cirrhosis: 1, 2, 3
- acute hbv infection and liver cirrhosis: 1, 2, 3
- acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute infection and additional benefit: 1, 2, 3
- acute infection and adenoviral vector: 1
- acute infection and adenovirus antibody: 1
- acute infection and liver biopsy: 1, 2, 3, 4, 5, 6
- acute infection and liver cirrhosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute infection resolve and liver cirrhosis: 1
Co phrase search for related documents, hyperlinks ordered by date